Call for information/EOI for neutralising antibodies.

Publication reference: 2021/S 000-024806
Publication date: 5 October 2021

F01: Prior information notice

Prior information only

Section one: Contracting authority

one.1) Name and addresses

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

Contact

Amjad Kazmi

Email

amjad.kazmi@dhsc.gov.uk

Country

United Kingdom

NUTS code

UKI32 - Westminster

Internet address(es)
Main address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

Buyer's address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

http://health.atamis.co.uk

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Call for information/EOI for neutralising antibodies.

two.1.2) Main CPV code
  • 33600000 - Pharmaceutical products
two.1.3) Type of contract

Supplies

two.1.4) Short description

DHSC invites suppliers to submit an EOI on neutralising antibodies andbinding site, clinical trials on efficacy, safetyfor preventing or treating COVID-19infection, dose&frequency, formats/routesfor administering to patients, monitoringadverse affects, efficacy against SARSCoV-2 variants, supply availability for 2021-2022 and future years and plans forregulatory approval in the UK, if not yetapproved.

two.1.5) Estimated total value

Value excluding VAT: £1

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance
NUTS codes
  • UK - United Kingdom
two.2.4) Description of the procurement

The Department is interested in engaging with the emerging market through expressions of interest prior to the publication of a contract notice to findinnovative neutralising antibody COVID-19 therapies that could inform the specification of requirements,conditions of contract and commercial model. Further details of how suppliers may engage with the Departmentare included in section VI.3) (additional information) at the end of this notice.

two.2.14) Additional information

Interested parties should submit questions via Atamis. Department welcomes discussions with interested parties on areas provision of a value for money solution for the UK tax payer;creating mechanisms for money solution for the UK tax payer;creating mechanisms (including but not limited to agreements) to secure long-term, guaranteed supply contracts with ‘step-in’ rights in future pandemics

two.3) Estimated date of publication of contract notice

31 March 2022


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section six. Complementary information

six.3) Additional information

This Prior Information Notice has been issued to alert the market for the possible procurement of neutralising antibodies. Suppliers should submit expressions of interest.